Gut damage during hemorrhagic shock: Effects on survival of oral or enteral interleukin-6

Shock

Volumn 16, Issue 6, 2001, Pages 449-453

  Wu, Xianren ^a   Prueckner, Stephan ^a   Rollwagen, Florence ^d   Kentner, Rainer ^a   Stezoski, Jason ^a   Kochanek, Patrick M ^a   Behringer, Wilhelm ^a   Pasculle, William A ^c   Safar, Peter ^a   Tisherman, Samuel A ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Hemorrhagic shock; Interleukin 6; Intestine; Rats; Survival

Indexed keywords

INTERLEUKIN 6;

ANIMAL; ARTICLE; DIGESTIVE SYSTEM; DRUG EFFECT; HEMORRHAGIC SHOCK; INJURY; ISCHEMIA; MALE; ORAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; RAT; RAT STRAIN; RESUSCITATION; VASCULARIZATION;

ADMINISTRATION, ORAL; ANIMAL; DIGESTIVE SYSTEM; INTERLEUKIN-6; ISCHEMIA; MALE; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; SHOCK, HEMORRHAGIC; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0035653335     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200116060-00008     Document Type: Article

References (34)

1. Lillie RC: The intestinal factor in irreversible hemorrhagic shock. Surgery 42:1043-1054, 1957.
2. Haglund U: Systemic mediators released from the gut in critical illness. Crit Care Med 21:S15-S18, 1993.
3. Smail N, Catania RA, Wang P, Cioffi WG, Bland KI, Chaudry IH: Gut and liver: the organs responsible for increased nitric oxide production after traumahemorrhage and resuscitation. Arch Surg 133:399-405, 1998.
4. Deitch EA, Xu D, Franko L, Ayala A, Chaudry IH: Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock 1:141-145, 1994.
5. Magnotti LJ, Upperman JS, Xu DZ, Lu Q, Deitch EA: Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Ann Surg 228:518-527, 1998.
6. Mailman D: Modulation of hemorrhagic shock by intestinal mucosal NG-Nitro-L-arginine and L-arginine in the anesthetized rat. Shock 12:155-160, 1999.
7. O'Donnell KA, Caty MG, Zheng S, Rossman JE, Azizkhan RG: Oxygenated intraluminal perfluorocarbon protects intestinal muscosa from ischemia/reperfusion injury. J Pediatr Surg 32:361-365, 1997.
8. Haglund U: Therapeutic potential of intraluminal oxygenation. Crit Care Med 21:S69-S71, 1993.
9. Flynn WJJ, Gosche JR, Garrison RN: Intestinal blood flow is restored with glutamine or glucose suffusion after hemorrhage. J Surg Res 52:499-504, 1992.
10. Barr J, Prueckner S, Safar P, Tisherman SA, Radovsky A, Stezoski J, Eshel G: Peritoneal ventilation with oxygen improves outcome after hemorrhagic shock in rats. Crit Care Med 28:3896-3901, 2000.
11. Rollwagen FM, Li YY, Pacheco ND, Baqar S: Systemic sepsis following hemorrhagic shock: alleviation with oral interleukin-6. Mil Med 162:366-370, 1997.
12. Rollwagen FM, Li YY, Pacheco ND, Nielsen TB: Systemic bacteraemia following haemorrhagic shock in mice: alleviation with oral interleukin 6. Cytokine 8:121-129, 1996.
13. Rollwagen FM, Gafney WC, Pacheco ND, Davis TA, Hickey TM, Nielsen TB, Rudolph AS: Multiple responses to administration of liposome-encapsulated hemoglobin (LEH): effects on hematopoiesis and serum IL-6 levels. Exp Hematol 24:429-436, 1996.
14. Rollwagen FM, Yu ZY, Li YY, Pacheco ND: IL-6 rescues enterocytes from hemorrhage induced apoptosis in vivo and in vitro by a bcl-2 mediated mechanism. Clin Immunol Immunopathol 89:205-213, 1998.
15. Qu XW, Rozenfeld RA, Huang W, Sun X, Tan XD, Hsueh W: Roles of nitric oxide synthases in platelet-activating factor-induced intestinal necrosis in rats. Crit Care Med 27:356-364, 1999.
16. Pearce FJ, Connett RJ, Drucker WR: Phase-related changes in tissue energy reserves during hemorrhagic shock. J Surg Res 39:390-398, 1985.
17. Johnson KB, Wiesmann WP, Pearce FJ: The effect of hypothermia on potassium and glucose changes in isobaric hemorrhagic shock in the rat. Shock 6:223-229, 1996.
18. Biffl WL, Moore EE, Moore FA, Peterson VM: Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 224:647-664, 1996.
19. Hoch RC, Rodriguez R, Manning T, Bishop M, Mead P, Shoemaker WC, Abraham E: Effects of accidental trauma on eytokine and endotoxin production. Crit Care Med 21:839-845, 1993.
20. Meade P, Shoemaker WC, Donnelly TJ, Abraham E, Jagels MA, Cryer HG, Hugi TE, Bishop MH, Wo CC: Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury. J Trauma 36:651-657, 1994.
21. Hierholzer C, Kalff JC, Omert L, Tsukada K, Loeffert JE, Watkins SC, Billiar TR, Tweardy DJ: Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury. Am J Physiol 275:L611-L621, 1998.
22. Biffl WL, Moore EE, Moore FA, Carl VS, Kim FJ, Franciose RJ: Interleukin-6 potentiates neutrophil priming with platelet-activating factor. Arch Surg 129:1131-1136, 1994.
23. Mullen PG, Windsor AC, Walsh CJ, Fowler AA, Sugerman HJ: Tumor necrosis factor-alpha and interleukin-6 selectively regulate neutrophil function in vitro. J Surg Res 58:124-130, 1995.
24. Preiser JC, Schmartz D, Van der Linden P, Content J, Vanden Bussche P, Buurman W, Sebald W, Dupont E, Pinsky MR, Vincent JL: Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog. Cytokine 3:1-4, 1991.
25. Aderka D, Maor Y, Novick D, Engelmann H, Kahn Y, Levo Y, Wallach D, Revel M: Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta. Blood 81:2076-2084, 1993.
26. Aderka D, Le JM, Vilcek J: IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 143:3517-3523, 1989.
27. Ulich TR, Yin S, Guo K, Yi ES, Remick D, del Castillo J: Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol 138:1097-1101, 1991.
28. Camargo CAJ, Madden JF, Gao W, Selvan RS, Clavien PA: Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26:1513-1520, 1997.
29. Meng ZH, Dyer K, Billiar TR, Tweardy DJ: Distinct effects of systemic infusion of G-CSF vs. IL-6 on lung and liver inflammation and injury in hemorrhagic shock. Shock 14:41-48, 2000.
30. Chang TW: Improvement of survival from hemorrhagic shock by enterectomy in rats: Finding to implicate the role of the gut for irreversibility of hemorrhagic shock. J Trauma 42:223-230, 1997.
31. Wang P, Ba ZF, Cioffi WG, Bland KI, Chaudry IH: Is gut the "motor" for producing hepatocellular dysfunction after trauma and hemorrhagic shock? J Surg Res 74:141-148, 1998.
32. Deitch EA: Animal models of sepsis and shock: A review and lessons learned. Shock 9:1-11, 1998.
33. Fazal N, Shamim M, Khan SS, Gamelli RL, Sayeed MM: Neutrophil depletion in rats reduces burn-injury induced intestinal bacterial translocation. Crit Care Med 28:1550-1555, 2000.
34. Langkamp-Henken B, Kudsk KA, Proctor KG: Fasting-induced reduction of intestinal reperfusion injury. J Parenter Enteral Nutr 19:127-132, 1995.